{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-003526","form_type":"8-K","ticker":"LUCD","cik":"0001799011","company_name":"Lucid Diagnostics Inc.","filed_at":"2025-04-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.758595+00:00","generated_at":"2026-05-23T17:23:40.469452+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Lucid Diagnostics prices $15M public offering of 12.5M shares at $1.20 per share","bullets":["Gross proceeds ~$15M from 12.5M shares at $1.20; underwriters have 45-day option for 1.875M additional shares.","Closing expected April 11, 2025; net proceeds for working capital and general corporate purposes.","Canaccord Genuity sole bookrunner, Maxim Group co-manager; offered under shelf registration effective Dec 2022.","Offering significantly dilutes existing shareholders; exact dilution depends on option exercise."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-003526","json":"https://secwatch.observer/filing/0001641172-25-003526.json","markdown":"https://secwatch.observer/filing/0001641172-25-003526.md","text":"https://secwatch.observer/filing/0001641172-25-003526.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799011/000164117225003526/0001641172-25-003526-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799011/000164117225003526/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T17:23:40.469452+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}